Search Results - technology+classifications+%3e+medical+%3e+infectious+diseases

38 Results Sort By:
Mecamylamine as a Therapeutic Agent for SARS-CoV-2
­Advantages: A new method of treating severe acute respiratory syndrome (SARS-CoV-2) Mecamylamine, a nicotinic receptor antagonist, blocks virus and nAChR receptor binding and decreases SARS-COV-2 replication in virus-infected Calu-3 cells Mecamylamine decreases cytokine expression in MHV4-infected IMG cells and manages inflammatory conditions Mecamylamine...
Published: 9/24/2024   |   Inventor(s): Paul Sanberg, Christian Brechot
Keywords(s): Respiratory Diseases Treatment
Category(s): Technology Classifications > Medical > Infectious Diseases
Methods for Treating Covid-19 Based on Individual Genomic Profiles
­Advantages: A high-throughput method offers a rapid and efficient way to predict severe outcomes in COVID-19 patients, facilitating faster clinical decision-making for pulmonary injury. Can be integrated with clinical variables to improve triage across healthcare settings, potentially reducing hospital stays, and optimizing resource allocation...
Published: 7/16/2024   |   Inventor(s): Jose Herazo-Maya, Brenda Juan-Guardela, Gaetane Michaud
Keywords(s):  
Category(s): Technology Classifications > Medical > Infectious Diseases, Technology Classifications > Medical > Respiratory, Technology Classifications > Medical > Therapeutics
An Automatic System of Tagging and Uploading of Mosquito Species from Smartphone Images
Competitive Advantages Cloud-based system Real-time identification and reporting Minimal to zero human intervention is required Time and cost savings Improved accuracy Summary Our inventors have developed a method for automatic identification of mosquito genus, species, and anatomy from smart-phone images. The method involves anyone (including...
Published: 6/26/2024   |   Inventor(s): Sriram Chellappan, Pratool Bharti, Mona Minakshi, Willie McClinton, Jamshidbek Mirzakhalov
Keywords(s):  
Category(s): Technology Classifications > Energy & Environment, Technology Classifications > Medical > Infectious Diseases, Technology Classifications > Software
Corona Discharge Based Treatments Of Articles
­Advantages: No high-temperature damage and less time/energy consumption compared with heating sterilization such as autoclave. Non-contact, negligible corrosion, reusable and environmentally friendly compared with chemical disinfections. More efficient compared with UV radiation by several magnitudes. Operator friendly, and safe to skin,...
Published: 5/29/2024   |   Inventor(s): Ying Zhong, Libin Ye
Keywords(s): Anti-Microbials
Category(s): Technology Classifications > Medical > Medical Devices, Technology Classifications > Medical > Infectious Diseases
Methods and Techniques to Classify Stages in the Gonotrophic Cycle of Mosquitoes from Images using Computer Vision Techniques
­Advantages: Enables rapid and accurate identification of mosquito gonotrophic stages, enhancing disease surveillance efforts effectively. Reduces the need for extensive entomological expertise, making mosquito monitoring more accessible and efficient. Facilitates integration with citizen-science platforms, empowering community involvement...
Published: 5/23/2024   |   Inventor(s): Sriram Chellappan, Farhat Azam, Ryan Carney, Sherzod Kariev
Keywords(s): Artificial Intelligence, Infectious Diseases, Predictive Analytics
Category(s): Technology Classifications > Medical > Infectious Diseases, Technology Classifications > Data/AI > D/AI Imaging, Technology Classifications > Computer Science > Algorithms
Regulated Delivery of Antibiotic and Antifungal Drugs Via Controlled Degradable Chondroitin Sulfate Particles
­Advantages: Novel synthesis of Chondroitin sulfate (CS) particles for encapsulation of antibiotic and antifungal drugs. Synthesis can be fine-tuned to produced non-degradable, slightly degradable, and completely degradable CS drug carriers, for a variety of therapeutic applications. CS particles were successfully tested for encapsulation...
Published: 5/14/2024   |   Inventor(s): NURETTIN SAHINER, Ramesh Ayyala
Keywords(s): Drug Delivery and Nanomedicine, Pharmaceuticals
Category(s): Technology Classifications > Medical > Cell & Tissue Engineering, Technology Classifications > Medical > Infectious Diseases, Technology Classifications > Medical > Therapeutics, Technology Classifications > Medical
Receptor Binding Domain 2 of CDTb Component of the Clostridioides Difficile Binary Toxin CDT as a Vaccine Component Against C. Difficile Infection
­Advantages: Enhanced Vaccine Conservation: This technology ensures the conservation of critical vaccine components across diverse C. difficile strains, improving vaccine effectiveness. Immunogenic Potential: RBD2, a key discovery, exhibits exceptional immunogenicity, promising robust immune responses in vaccine recipients. Inhibition of CDT...
Published: 9/3/2024   |   Inventor(s): Xingmin Sun, Shaohui Wang
Keywords(s): Infectious Diseases, Vaccines
Category(s): Technology Classifications > Medical > Infectious Diseases
Recombinant Fusion Protein Containing Clostridioides Difficile Flagellin Proteins FliC and FliD as a Vaccine Candidate Against C. Difficile Infection
­Advantages: Novel Vaccine Approach: Vacine targeting C. difficile flagellar proteins FliC and FliD. Enhanced Protection: FliCD provides robust immunity, reduces C. difficile infection severity, and decreases spore and toxin levels in feces. Potential Alternative Therapy: Anti-FliCD serum demonstrates promise as an adjunct therapy for CDI,...
Published: 2/13/2024   |   Inventor(s): Xingmin Sun
Keywords(s): Infectious Diseases, Vaccines
Category(s): Technology Classifications > Medical > Infectious Diseases
New natural product scaffolds with activity against respiratory syncytial virus from the Antarctic Sponge Suberites sp.
­Advantages: This research introduces a novel class of compounds, including neosuberitenone, which demonstrates selectivity against respiratory syncytial virus (RSV). The research's focus on small molecules derived from a natural source, the Antarctic sponge Suberites sp., hints at the potential for cost-effective treatments. The identified...
Published: 11/7/2024   |   Inventor(s): Bill Baker, Joe Bracegirdle, Stine Olsen, Michael Teng, Kim Tran, Charles Amsler, James McClintock
Keywords(s): Antiviral Therapeutics, Infectious Diseases Treatment, Respiratory Diseases Treatment
Category(s): Technology Classifications > Medical > Therapeutics, Technology Classifications > Medical > Respiratory, Technology Classifications > Medical > Pharmaceuticals, Technology Classifications > Medical > Infectious Diseases
Novel Small Molecule Inhibitors Targeting Clostridioides Difficile Sporulation
­Advantages: The development of DBO compounds represents a novel therapeutic approach to tackling CDI. By inhibiting C. difficile sporulation, DBO compounds address a major cause of CDI recurrence, reducing the likelihood of patients experiencing repeated infections. DBO compounds improve the effectiveness of existing antibiotics used to treat...
Published: 10/2/2023   |   Inventor(s): Yu Chen, Michael Sacco, James Leahy, Elena Bray, Xingmin Sun, Xiujun Zhang
Keywords(s): Drug Discovery, Infectious Diseases Treatment
Category(s): Technology Classifications > Medical > Therapeutics, Technology Classifications > Medical > Pharmaceuticals, Technology Classifications > Medical > Medical Diagnostics, Technology Classifications > Medical > Infectious Diseases, Technology Classifications > Medical > Biotechnology
1 2 3 4